Fox Run Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,525
| Closed | -$315K | – | 1177 |
|
|
2025
Q1 | $315K | Buy |
59,525
+28,447
| +92% | +$150K | 0.05% | 658 |
|
|
2024
Q4 | $210K | Buy |
+31,078
| New | +$210K | 0.04% | 745 |
|
|
2024
Q3 | – | Sell |
-12,311
| Closed | -$92.3K | – | 1064 |
|
|
2024
Q2 | $92.3K | Sell |
12,311
-1,758
| -12% | -$13.2K | 0.02% | 727 |
|
|
2024
Q1 | $140K | Buy |
+14,069
| New | +$140K | 0.03% | 682 |
|
|
2023
Q3 | – | Sell |
-18,917
| Closed | -$141K | – | 955 |
|
|
2023
Q2 | $141K | Buy |
18,917
+2,183
| +13% | +$16.3K | 0.04% | 619 |
|
|
2023
Q1 | $112K | Buy |
+16,734
| New | +$112K | 0.04% | 592 |
|